XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Shareholders’ Equity and Redeemable Noncontrolling Interest (unaudited) - USD ($)
Total
Common Stock
Deferred Equity Compensation
Retained Earnings
Beginning balance (shares) at Dec. 31, 2022   3,010,457    
Beginning Balance at Dec. 31, 2022 $ 163,672,245 $ 51,688,631 $ (17,011,144) $ 128,994,758
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of restricted stock grants (shares)   49,099    
Issuance of restricted stock grants   $ 9,400,986 (9,400,986)  
Amortization of restricted stock grants 2,843,574   2,843,574  
Issuance of common stock related to 401k plan match (in shares)   46    
Issuance of common stock related to 401k plan match 7,843 $ 7,843    
Issuance of common stock related to employee stock purchase plan (in shares)   1,963    
Issuance of common shares related to employee stock purchase plan 323,070 $ 323,070    
Shares withheld related to employee tax withholding (in shares)   (6,121)    
Shares withheld related to employee tax withholding (1,132,507) $ (1,132,507)    
Repurchase of common stock (shares)   (27,706)    
Repurchase of common stock (4,597,931) $ (4,597,931)    
Cash dividends paid (4,576,492)     (4,576,492)
Net income 12,707,552     12,707,552
Ending balance (shares) at Mar. 31, 2023   3,027,738    
Ending Balance at Mar. 31, 2023 169,247,354 $ 55,690,092 (23,568,556) 137,125,818
Beginning balance attributable to redeemable noncontrolling Interests at Dec. 31, 2022 14,126,198      
Increase (Decrease) in Temporary Equity [Roll Forward]        
Net Income Attributable to Redeemable Noncontrolling Interest (1,395,495)      
Net subscriptions of consolidated funds 1,811,105      
Ending balance attributable to redeemable noncontrolling Interests at Mar. 31, 2023 17,332,798      
Increase (Decrease) in Temporary Equity [Roll Forward]        
Accrued excise tax $ 27,805      
Beginning balance (shares) at Dec. 31, 2023 2,823,076 2,823,076    
Beginning Balance at Dec. 31, 2023 $ 160,316,808 $ 22,164,410 (15,392,418) 153,544,816
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of restricted stock grants (shares)   72,032    
Issuance of restricted stock grants   $ 11,058,398 (11,058,398)  
Amortization of restricted stock grants 3,259,239   3,259,239  
Issuance of common stock related to employee stock purchase plan (in shares)   1,688    
Issuance of common shares related to employee stock purchase plan 260,239 $ 260,239    
Shares withheld related to employee tax withholding (in shares)   (6,372)    
Shares withheld related to employee tax withholding (1,055,140) $ (1,055,140)    
Forfeiture of restricted stock grants (shares)   (648)    
Forfeiture of restricted stock grants 0 $ (116,192) 116,192  
Repurchase of common stock (shares)   (85,108)    
Repurchase of common stock (13,282,117) $ (13,282,117)    
Cash dividends paid (4,229,322)     (4,229,322)
Net income $ 13,015,933     13,015,933
Ending balance (shares) at Mar. 31, 2024 2,804,668 2,804,668    
Ending Balance at Mar. 31, 2024 $ 158,285,640 $ 19,029,598 $ (23,075,385) $ 162,331,427
Increase (Decrease) in Temporary Equity [Roll Forward]        
Accrued excise tax $ 126,747